Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Innovation Marks Medical Device and Therapy Provider as Company to Watch

Accesswire May 28, 2013

Start Making Profits Now With ANF, VRX, JNJ and GLW

Marketwired May 25, 2013

In the Know, Smart Investing in PHM, CX, JNJ and PPL

Marketwired May 24, 2013

Free Research Reports on ELN, JNJ, QSII and SIG Issued by the Paragon Report

Marketwired May 24, 2013

EmergingGrowth.com Looks at New Payment Platform, Record Numbers Company

Accesswire May 23, 2013

Johnson & Johnson Pharmaceuticals Segment Poised to Continue Driving Growth with More than 10 Potential New Product Filings by 2017

PR Newswire May 23, 2013

Special Offer for Shareholders of JNJ, KO, CLNT and SAN

Marketwired May 23, 2013

Cordis Showcases Cardiovascular Innovations at EuroPCR 2013

Business Wire May 21, 2013

Secrets to Making Money in NEM, SPF, XRX and JNJ

Marketwired May 18, 2013

Free Research Reports on DRYS, INFI, JNJ and SCTY Issued by the Bedford Report

Marketwired May 17, 2013

The Straight Truth, Investing in JNJ, MGM, DNDN and AGNC

Marketwired May 15, 2013

StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX

Accesswire May 15, 2013

Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH(TM) Catheter

Business Wire May 13, 2013

Special Situation Coming Soon, a Look Inside DDD, JNJ, MRK and EXC

Marketwired May 11, 2013

Strategy Behind Our Success, We Get in Early: WMB, AMZN, IBM and JNJ

Marketwired May 10, 2013

First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Electrode nMARQ(TM) Pulmonary Vein Isolation System(TM) in the Treatment of Paroxysmal Atrial Fibrillation

Business Wire May 9, 2013

Perfect Trade Setups, How to Play PFE, F, JNJ and INTC

Marketwired May 8, 2013

Biosense Webster Showcases Cutting Edge Innovation and Leadership in AF Ablation at HRS Annual Scientific Sessions 2013

Business Wire May 8, 2013

Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)

PR Newswire May 2, 2013

The Reason It Trades, What's Moving JNJ, XOM, C and IBM

Marketwired May 2, 2013